These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 16835328)

  • 1. A role for XRCC4 in age at diagnosis and breast cancer risk.
    Allen-Brady K; Cannon-Albright LA; Neuhausen SL; Camp NJ
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1306-10. PubMed ID: 16835328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new single nucleotide polymorphism in XRCC4 gene is associated with breast cancer susceptibility in Taiwanese patients.
    Chiu CF; Wang HC; Wang CH; Wang CL; Lin CC; Shen CY; Chiang SY; Bau DT
    Anticancer Res; 2008; 28(1A):267-70. PubMed ID: 18383855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ERCC2 genotypes and a corresponding haplotype are linked with breast cancer risk in a German population.
    Justenhoven C; Hamann U; Pesch B; Harth V; Rabstein S; Baisch C; Vollmert C; Illig T; Ko YD; Brüning T; Brauch H
    Cancer Epidemiol Biomarkers Prev; 2004 Dec; 13(12):2059-64. PubMed ID: 15598761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis.
    Pearce CL; Hirschhorn JN; Wu AH; Burtt NP; Stram DO; Young S; Kolonel LN; Henderson BE; Altshuler D; Pike MC
    J Natl Cancer Inst; 2005 Jan; 97(1):51-9. PubMed ID: 15632380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families.
    Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J
    BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.
    Haiman CA; Stram DO; Pike MC; Kolonel LN; Burtt NP; Altshuler D; Hirschhorn J; Henderson BE
    Hum Mol Genet; 2003 Oct; 12(20):2679-92. PubMed ID: 12944421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms XRCC1-R399Q and XRCC3-T241M and the risk of breast cancer at the Ontario site of the Breast Cancer Family Registry.
    Figueiredo JC; Knight JA; Briollais L; Andrulis IL; Ozcelik H
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):583-91. PubMed ID: 15066923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan.
    Yen CY; Liu SY; Chen CH; Tseng HF; Chuang LY; Yang CH; Lin YC; Wen CH; Chiang WF; Ho CH; Chen HC; Wang ST; Lin CW; Chang HW
    J Oral Pathol Med; 2008 May; 37(5):271-7. PubMed ID: 18410587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer.
    Zhang Y; Newcomb PA; Egan KM; Titus-Ernstoff L; Chanock S; Welch R; Brinton LA; Lissowska J; Bardin-Mikolajczak A; Peplonska B; Szeszenia-Dabrowska N; Zatonski W; Garcia-Closas M
    Cancer Epidemiol Biomarkers Prev; 2006 Feb; 15(2):353-8. PubMed ID: 16492928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
    Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
    Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prospective study of XRCC1 haplotypes and their interaction with plasma carotenoids on breast cancer risk.
    Han J; Hankinson SE; De Vivo I; Spiegelman D; Tamimi RM; Mohrenweiser HW; Colditz GA; Hunter DJ
    Cancer Res; 2003 Dec; 63(23):8536-41. PubMed ID: 14679022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer.
    Choi JY; Lee KM; Park SK; Noh DY; Ahn SH; Chung HW; Han W; Kim JS; Shin SG; Jang IJ; Yoo KY; Hirvonen A; Kang D
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1090-5. PubMed ID: 15894657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D pathway gene polymorphisms, diet, and risk of postmenopausal breast cancer: a nested case-control study.
    McCullough ML; Stevens VL; Diver WR; Feigelson HS; Rodriguez C; Bostick RM; Thun MJ; Calle EE
    Breast Cancer Res; 2007; 9(1):R9. PubMed ID: 17244366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A haplotype-based case-control study of BRCA1 and sporadic breast cancer risk.
    Freedman ML; Penney KL; Stram DO; Riley S; McKean-Cowdin R; Le Marchand L; Altshuler D; Haiman CA
    Cancer Res; 2005 Aug; 65(16):7516-22. PubMed ID: 16103107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1 breast cancer risk is modified by CYP19 polymorphisms in Ashkenazi Jews.
    Raskin L; Lejbkowicz F; Barnett-Griness O; Dishon S; Almog R; Rennert G
    Cancer Epidemiol Biomarkers Prev; 2009 May; 18(5):1617-23. PubMed ID: 19366906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of single nucleotide polymorphisms and haplotypes in BRCA1 in breast cancer: Czech case-control study.
    Soucek P; Borovanova T; Pohlreich P; Kleibl Z; Novotny J
    Breast Cancer Res Treat; 2007 Jun; 103(2):219-24. PubMed ID: 17039264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Common variation in BRCA2 and breast cancer risk: a haplotype-based analysis in the Multiethnic Cohort.
    Freedman ML; Penney KL; Stram DO; Le Marchand L; Hirschhorn JN; Kolonel LN; Altshuler D; Henderson BE; Haiman CA
    Hum Mol Genet; 2004 Oct; 13(20):2431-41. PubMed ID: 15317758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen receptor genotypes and haplotypes associated with breast cancer risk.
    Gold B; Kalush F; Bergeron J; Scott K; Mitra N; Wilson K; Ellis N; Huang H; Chen M; Lippert R; Halldorsson BV; Woodworth B; White T; Clark AG; Parl FF; Broder S; Dean M; Offit K
    Cancer Res; 2004 Dec; 64(24):8891-900. PubMed ID: 15604249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction between genetic variations in DNA repair genes and plasma folate on breast cancer risk.
    Han J; Hankinson SE; Zhang SM; De Vivo I; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2004 Apr; 13(4):520-4. PubMed ID: 15066914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study.
    Tseng RC; Hsieh FJ; Shih CM; Hsu HS; Chen CY; Wang YC
    Cancer; 2009 Jul; 115(13):2939-48. PubMed ID: 19408343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.